Navigation Links
Video: Beyond the Red Door: Gilda's Club Worldwide and DKNY Host Successful Benefit Event
Date:10/3/2007

r, whatever the outcome.

About DKNY

Donna Karan International is one of the world's leading fashion design houses. It designs, markets and distributes collections of women's and men's apparel, sportswear, accessories and shoes under the Donna Karan Collection and DKNY brand names. The Company has selectively granted licenses for the manufacture and distribution of beauty and beauty related products, jeanswear, activewear, men's furnishings, hosiery, intimate apparel, coats, children's apparel and home. Donna Karan International has been part of the LVMH Moet Hennessy Louis Vuitton Group since November 2001.


'/>"/>
SOURCE Gilda's Club Worldwide
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Life Beyond Cancer - Delhi Woman Tells How
2. Intel Outside: Exploring Life beyond the Chip
3. Latest Drug for AMD, Beyond The Reach Of Common Man
4. Medical Course in Kerala is Beyond the Reach of NRIs
5. Babies Breast-fed beyond Nine Months at Risk of Allergies
6. Beyond Bifocals: Wavefront Technology Benefits Patients With Presbyopia
7. Rotavirus can Spread Beyond the Intestine
8. Alcohol a potential carcinogen: knocking on the door: pay heed!
9. Drop in Worldwide Measles deaths by 40%
10. Drugs Banned worldwide still available in India
11. Domestic Violence: The Silent Killer of Women Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...But researchers remain cautious about future antib..., FRIDAY, Nov. 21 (HealthDay News) -- People with...disease (COPD) may be able to reduce the frequency... common antibiotic, a new report says. , The s... the American Journal of Respiratory and Critical...
(Date:11/21/2008)...MORGANTOWN, W.Va., Nov. 21 /PRNewswire-USNewswire/...examining whether a smokeless, spitless tobacco pr...e researchers have found that RJ Reynolds, Camel S...fy addiction - contains surprisingly high levels o...icotine than most other snuff products," said Bruc...
(Date:11/21/2008)...NEW YORK, Nov. 21 The general memb...ted to induct three new individuals at their Annua...he Pierre hotel in New York. A,Lifetime Achieveme...uctees into the Medical Advertising Hall of Fame a...g career with an account position,at Sudler &...
(Date:11/21/2008)...Experiments in mice find running increases product.... 21 (HealthDay News) -- In experiments in mice, e...uction of brain stem cells usually seen with aging...le restoration of the brain,s ability to stave off...restore a neurochemical that is essential for the ...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:Exercise Keeps the Brain Young 2
...n models were kicked out of a Rome fashion show la... on anorexia in the fashion industry . "I asked t...k ... (and) had to fire 15 who were under (French)...)," Raffaella Curiel told reporters. "One girl fa...
... antibiotics daily to prevent future urinary tract...ot be such a good idea , for not only does it not ...hat bacteria causing the infection might develop r...g is based on the first large study of children di...
...chers reported the substance, known as adiponecti...ergy expenditure in an effort to maintain adequate...tein known for its effects on the liver and skelet...e as an energy-conserving signal to the brain duri...
...seems to be an acute shortage of jobs for the phys...d physiotherapists cannot find a permanent job in...There is huge waiting list of patients waiting for...inancial cutback last year to balance health servi...
Other Medicine News:Health News:Daily Antibiotics may Not Prevent Future Urinary Tract Infections Risk in Kids 2Health News:Insulin Sensitizer- Energy Conserving Signal to Brain 2Health News:Physios Find It Difficult to Find Job in NHS 2
(Date:11/20/2008)...ASHINGTON, Nov. 20 The ...amp; Gender Equity: , , WHAT: World AIDS ... Tuesday, November 25, 2008 , 11:00 a.m. EST ...ngly encouraged: https://cc.readytalk.com/r/1xe41...s outpacing the number of people newly put on trea...
(Date:11/20/2008)..., , , , PHILADELPHIA, Nov. 20 /PRNe... today announced that the United States Food and D...val for PROMACTA(R) (eltrombopag) for the treatmen...une (idiopathic) thrombocytopenic purpura (ITP) wh...oids, immunoglobulins or splenectomy. The approval...
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswire-F...hat the Anti-infective Drugs Advisory Committee of...voted 17 to 2 against the,approval of intravenous...for,the treatment of patients with complicated sk...ing those caused by methicillin-resistant Staphylo...
(Date:11/20/2008)...MERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCall/ ...company will present results from the Phase 1B,cl...nced metastatic breast,cancer, BZL101, at the Soc...l,Conference in Atlanta, Georgia. The Company,s ...bstract and will be presented as a part of the Bes...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 11583 1Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 11583 2MIT develops thin film micro pharmacy 11580 1MIT develops thin film micro pharmacy 11580 2Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 11575 1Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 11575 2Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 11575 3Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 1Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 2Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 3Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 4Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 5Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 6Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 7Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 8Hanger Orthopedic Group Inc Announces an 11 25 Sales Increase and a 35 25 Increase in EPS to 240 23 for the Quarter Ended December 31 2007 Compar 11570 9
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: